Pharmacodynamic Evaluation of Interferon α-2b Inhalation Powder by RT-PCR

JING Rong-go;WNG Li-qing;LIU Heng;WNG Chun-long

Chinese Pharmaceutical Journal ›› 2007, Vol. 42 ›› Issue (22) : 1692-1695.

Chinese Pharmaceutical Journal ›› 2007, Vol. 42 ›› Issue (22) : 1692-1695.
论著

Pharmacodynamic Evaluation of Interferon α-2b Inhalation Powder by RT-PCR

  • JIANG Rong-gao,WANG Li-qing,LIU Heng,WANG Chun-long
Author information +
History +

Abstract

OBJECTIVE To evaluate the pharmacodynamic effects of recombinant human interferon α-2b (IFN α-2b) inhalation powder.METHODS 2′,5′-Oligoadenylate synthetase (OAS) was used as a surrogate marker for IFN α-2b induction,and a sensitive and semi-quantitative method was established by use of reverse transcription-polymerase chain reaction (RT -PCR) for the determination of OAS1 and OAS2 forms of OAS mRNA in peripheral blood mononuclear cells .RESULTS OAS1 mRNA concentration was equivalent after IFN α-2b was administrated by injection and inhalation,but the later administration route resulted in a higher OAS2 mRNA level.CONCLUSION IFN α-2b inhalation powder is promising to be a non-invasive systemic delivery route with excellent compliance.

Key words

interferon α-2b / inhalations powder / pharmacodynamic effects / RT-PCR / 2′ / 5′-oligoadenylate synthetase

Cite this article

Download Citations
JING Rong-go;WNG Li-qing;LIU Heng;WNG Chun-long. Pharmacodynamic Evaluation of Interferon α-2b Inhalation Powder by RT-PCR [J]. Chinese Pharmaceutical Journal, 2007, 42(22): 1692-1695

References

[1] CHIEUX V,HOBER D,CHEHADEH W,et al. Alpha interferon,antiviral proteins and their value in clinical medicine[J] . Ann Biol Clin,1999,57 (6): 659-666. [2] CHOUDHARY S,GAO J,LEANMAN D W,et al. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription[J] . J Virol,2001,75 (10):4823-4831. [3] BALAN V,NELSON D R,SULKOWSKI M S,et al. Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C[J] . Antivir Ther,2006,11(7): 901-908. [4] LUO S,CASSIDY W,JEFFERS L,et al. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy[J] . Clin Gastroenterol Hepatol,2005,3(5):499-506. [5] DONG B,SILVERMAN R H. 2-5A-dependent Rnase molecules dimerize during activation by 2-5A[J] . J Biol Chem,1995,270 (8): 4133-4137. [6] SAWAI H,ISHIBASHI K,ITOH M,et al. Sensitive radioimmuno assay for 2′,5′-oligoadenylates using a novel 125I-labeled derivative of 2′,5′-triadenylate 5′-triphosphate[J] . J Biochem,1985,98 (4): 999-1005. [7] FENG Y F,YANG K Y. A rapid non-isotope assay for 2′,5′-oligoadenylate synthetase[J] . Chin Biochem J(生物化学杂志),1997,13 (4): 428-431. [8] WILLS R J,DENNIS S,SPIEGEL H E,et al. Interferon kinetics and adverse reactions after intravenous,intramuscular,and subcutaneous injection[J] . Clin Pharmacol Ther,1984,35 (5):722-777.

Accesses

Citation

Detail

Sections
Recommended

/